HAL Allergy B.V.
- Address
- J.h. Oortweg 15-17
Sponsor Overview
Specializations
Allergic Rhinitis and Rhinoconjunctivitis
HAL Allergy B.V. focuses on moderate to severe allergic rhinitis and rhinoconjunctivitis linked to house dust mite sensitisation, including persistent nasal and ocular allergy symptoms in adults.
- Allergic rhinitis
- Rhinoconjunctivitis
- House dust mite allergy
The sponsor’s clinical interest is centred on allergy-driven upper airway disease and symptom control in affected adult populations.
Asthma Associated with Allergen Sensitisation
The company also studies asthma occurring alongside house dust mite-induced respiratory allergy, reflecting interest in patients with overlapping upper and lower airway involvement.
- Asthma
- Allergen-induced respiratory disease
- Combined airway allergy
This area includes clinical attention to respiratory symptoms that accompany perennial allergen exposure.
Subcutaneous Immunotherapy
HAL Allergy B.V. has a clear therapeutic focus on subcutaneous immunotherapy for house dust mite allergy, with work centred on allergy desensitisation in adults with clinically significant symptoms.
- Subcutaneous immunotherapy
- Allergen immunotherapy
- HDM-directed treatment
Its research activity in this field is directed toward therapeutic options for chronic allergic disease management.
Respiratory Allergy in Multicentre Clinical Settings
The sponsor is involved in clinical research on respiratory allergy across multiple European sites, supporting evaluation in diverse adult populations with perennial allergen exposure.
- Respiratory allergy
- Perennial allergen exposure
- Adult allergy care
This research domain reflects therapeutic interest in real-world allergic disease patterns across several countries.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy of PURETHAL Mites Mixture Subcutaneous Immunotherapy in Adults with Moderate to Severe House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis |  Austria Bulgaria Germany Latvia Lithuania Poland | Not Recruiting |
Data & Insights
This sponsor works with 29 molecules, of which 7 are not being studied by other sponsors.
This sponsor has worked with 71 sites across their trial portfolio.
Therapeutic Focus
- 1.Immune System Diseases1 trial322 other sponsors
Partnered Research Centres
71 centres- Address
- Seliu G. 64, Vilniaus M. Sav., 08109 Vilnius
- Address
- Pck 26 Street, 33-100 Tarnow
- Address
- Ul. Tomasza Drobnika 49, 60-693 Poznan
- Address
- ul. Jana Sapiehy 2 lok. 4A, 20-095 Lublin
- Address
- Al. Gen. Jozefa Hallera 95, 53-201 Wroclaw
- Address
- Karl Carstens Strasse 10, 53113 Bonn
Want to get in touch with this sponsor?
Send a question and we'll pass it on to HAL Allergy B.V..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.